Each consultant has an average of 30+ years of practical experience, from startups and turnarounds to transformational growth in niche and large diagnostic manufacturing, development, and service companies. Our team brings knowledge from every discipline of the laboratory industry. We have a hand-picked a list of “battle hardened” industry experts who are specialists and provide services nationally from Arizona, California, Connecticut, Louisiana, Oregon, Massachusetts, New Hampshire, New York and Texas.
True understanding of needs to deliver sustainable knowledge and solutions
MOMENTUM's approach is a unique blend of qualified advisory consulting approaches.
Compile input, feedback, knowledge and experience to develop implementable business solutions.
Advise and support clients to discover, develop and align on their solution
Your Result - Long Term Value and Positive Business Change
VALERIE B. PALMIERI, CEO of MOMENTUM Consulting, is an experienced executive leader of high growth disruptive Public and Private Biotech companies serving as Chairwoman, Board Member, CEO/President, Senior Executive and Consulting Principal with oversight for multiple locations, 1,000 + employees, including sales, marketing, customer retention, operations, research, compliance, quality assurance and finance. She has a specific focus in women’s health and FemTech serving as an advisor and board member to various women’s health and novel disruptive technology organizations.
Prior positions include Executive Chair of Aspira Women’s Health, CEO/President of Aspira Women’s Health, COO of Aspira Women’s Health, CEO/President of Diagnocure, Senior Vice President of Operations at Laboratory Corporation of America and DIANON Systems, Inc.
Ms. Palmieri possesses expertise in both large scale and start-up executive and operational management. Her skills include strategic business planning, commercialization of products, mergers and acquisitions, productivity, developing and maintaining client-focused partnerships, customer retention, supply chain management/logistics, operations, research, compliance, quality assurance and finance.
Ms. Palmieri received her BS degree in Medical Technology with honors from Western Connecticut State University, Mini MBA from Elon University, Certificate in Digital Health and Strategy from Columbia Business School Executive Education, Certificate in Corporate Governance from Stanford Directors College, Certificate in Corporate Governance from The Wharton School – University of Pennsylvania. She currently resides in Monroe, Connecticut with her family.
Mojgan Manshadi a Consultant with MOMENTUM, With over thirty years of experience in Laboratory Operations, Quality Management Systems, (ISO 9001, ISO 15189) Regulatory Affairs (State, CLIA, CAP, FDA), and Process improvement (Six Sigma, Lean) she Collaborates with clients to provide Practical, Effective, Efficient and Compliant Processes to Achieve Product and Service Excellence.
Mojgan Manshadi is board certified by the American Society of Clinical Pathology (ASCP), the California Clinical Laboratory Scientist (CLS) and is a Six Sigma Trained Black Belt.
She began her career at hospital-based laboratories where she served as a CLS rotating in Chemistry, Hematology and Special Chemistry departments. She gained her reference Laboratory experience starting at Nichols Institute and Quest Diagnostics laboratories where she played a critical role establishing Nichols Coagulation laboratory, implementing their Quality Management System, ISO 9001 Certifications and completing major Six Sigma projects.
In 2003 she joined US LABs in Irvine, California as the Director of Quality and Regulatory Affairs. After the acquisition of US LABS by Laboratory Corporation of America (Lab Corp), she served as the Vice President of Quality for the Esoteric Business Division where she standardized a universal Quality Management System throughout the Division. Later-on she was appointed as the Vice President/General Manager of USLABS one of the Lab Corp’s Oncology Division. Her last job before she left Lab Corp was the Vice President of Quality and Business Alignment of the Oncology Division of Lab Corp. She recently served as the Chief Operations Officer at Morningstar Laboratories and currently serves on the Board of the Friends of Family Clinic which is a Federally Qualified Health Center (FQHC).
A consultant with MOMENTUM, Ms. Miller has over twenty years experience in healthcare in urgent care, diagnostics, and anatomic pathology laboratory industries, serving in numerous leadership positions for sales, operations, and executive capacities for urgent care, occupational medicine, laboratory service, and capital equipment organizations. She began her sales leadership career at Ventana Medical Systems, Inc., and continued in senior sales leadership capacities at US Labs and DIANON Systems, both divisions of LabCorp. Ms. Miller served as General Manager and Director of Sales while at DIANON Systems, and General Manager and Senior Vice President of Pathology Solutions with PLUS Diagnostics. She served as the President – Pathology Service Division, Global Sales & Marketing for Laboratory and Urology Divisions for HealthTronics. Ms. Miller served as the Senior Vice President of Sales and Customer Experience at ASPIRA Laboratories, a Vermillion, Inc. Owned Company. Recently, Ms. Miller served as the CEO of SouthStar Urgent Care, a Shore Capital owned platform company. Ms. Miller is also a certified Gallup CliftonStrengths Coach and provides executive coaching. Prior to entering diagnostics, Ms. Miller served in the U.S. Army, where she achieved the rank of Captain – Military Intelligence. Ms. Miller currently resides in Lafayette, Louisiana with her family.
A consultant with MOMENTUM, Dr. Owens is a senior healthcare executive with extensive management experience leading clinical and surgical pathology reference laboratories, including clinical trial studies. Dr. Owens has a broad scientific background in anatomic and hematopathology, immunology, infectious disease, molecular oncology, and genetics and has held COO and SVP positions at national reference laboratories, including Knight Diagnostic Laboratories at Oregon Health & Science University, Caris Life Sciences, Genzyme Genetics/ IMPATH and Nichols Institute.
Her responsibilities included managing operating budgets up to $50MM, extensive experience in CLIA/CAP laboratory operations in startup, turnaround, and translational growth, business strategy development and implementation, operational efficiencies across multiple locations, management team development and successor planning. Her expertise spans startups, M&A and strategic planning.
Dr. Owens received her Ph.D in Medical Microbiology and Immunology (emphasis Tumor Immunology) at UCLA, her M.B.A.in Management and Strategy at Pepperdine University, and B.S., M.S in Microbiology (emphasis Microbial Genetics) at Long Beach State University. She resides in Oregon with her family.
A consultant with MOMENTUM Consulting, Ms. Steier has extensive background in raising capital and advising on Mergers & Acquisition transactions and licensing and strategic partnerships. Ms. Steier has over 20 years of Investment Banking and Capital Markets experience, with a focus on the healthcare industry.
Most recently, Ms. Steier was a Managing Director in the Healthcare Investment Banking group at Morgan Joseph TriArtisan where she focused on the Diagnostics, Genomics and Personalized Medicine sectors. Prior to that, Ms. Steier was with Emerging Growth Equities, a boutique Investment Banking firm located in Philadelphia, PA. Throughout her career, Ms. Steier has worked with both start-up, small-cap and mid-cap companies.
Ms. Steier graduated from Emory University with a BA in Economics and attended The London School of Economics studying International Finance.
A consultant with MOMENTUM, Mr. Stephens has over twenty plus years in this field of Histology. Mr. Stephens has been an early adopter of strategies that capitalize on emerging pathology markets. A Six Sigma Green Belt he works at the intersection of business strategy, patient safety, process improvement and employee advocacy. He regularly advises major healthcare institutions on improvement opportunities using Lean/Six sigma. He is a frequent speaker at state and national histotechnology symposia and has two patents pending in informatics pathology.
Mr. Stephens currently resides in Arizona as well as Texas.
A Consultant with MOMENTUM, Mr. Carpenter has extensive experience in operational aspects of laboratories. With over thirty years of experience in laboratories ranging from toxicology, anatomic, clinical, molecular, IVD, R&D, and veterinary he can combine the business aspects with the science to provide customers lean operations while not sacrificing quality.
Pat Carpenter is board certified by the American Society of Clinical Pathology, was a Responsible Person (RP) by the National Laboratory Certification Program (NLCP), both a FUDT and Clinical Laboratory Inspector for American Society of Clinical Pathologists and a LEAN 6 Sigma trained Green Belt.
He has acquired his vast knowledge in both small laboratories and among the largest labs in the country. He has held Director, GM and VP of Operations roles at Quest, LabCorp, DIANON, Miraca Life Sciences, AML/APL, Plus Diagnostics, Maryland Medical, US Air Force Drug Testing Laboratory, Aspira Women’s Health, and VCA/Antech.
Mr. Carpenter holds a BS in Business and Management from University of Maryland, a MA in Health Services Management from Webster University, and a MS in Biomedical Chemistry from Thomas Jefferson University. He is also a retired Air Force Colonel. He currently resides in New Hampshire with his family.
Associate Consultant, Mr. Standwill brings over 20 years industry experience in diagnostics and medical device. He held executive leadership positions for Sherlock Bio, Exact Sciences, T2 Bio and Leica Biosystems Danaher. His experience includes global markets, commercial channels, strategy and access levers for geographic expansion and shortened timelines.
Bill is a Danaher trained, tech savvy senior executive with transformative impact success adding immediate value to strategy, sales, marketing, productization and business development to support commercial milestones and corporate growth.
He earned his degree from the Rochester Institute of Technology and currently sits on the Executive Advisory Board for RIT FRAM Applied Critical Thinking.
Carlos María Galmarini is Topazium’s founder and CEO since 2019. He earned his Medical Degree from the University of Buenos Aires (Argentina), after which he completed an internship in clinical oncology at Marie Curie Cancer Center (Buenos Aires). He pursued two post-doctoral fellowships in oncology at Los Angeles City of Hope Cancer Center (USA) and at Léon Bérard Cancer Center (Lyon, France). He obtained his PhD in oncology and his qualification to lead research teams (HDR) at Claude Bernard Lyon-1 University (Lyon, France). Carlos María practiced medicine both at the Marie Curie and Carlos G. Durand Hospitals in Buenos Aires for several years. He has also held positions as a medical researcher in oncology at Lyon Rockefeller Medical School and in Lyon-Sud Medical School (France), where he was appointed Associate Professor. In 2008 he joined PharmaMar (Madrid, Spain) as Head of Cell Biology and Pharmacogenomics, where he was in charge of drug screening, biochemistry, molecular biology and pharmacogenomics areas. He has authored over 130 publications across leading international scientific journals. In recent years, he devoted his research to the application of artificial intelligence in healthcare, molecular biology and other related-medical fields, particularly, in the generation of diagnostic assistance tools (dermatological, ophthalmological, radiological and digital pathology areas) and predictive tools (virtual biomarkers and synthetic patients).
Greg Richard is an expert in driving growth in the healthcare market by effectively leading and implementing key drivers, primarily Sales and Marketing and Market Access, for over 20 years. He has successfully grown both start-up and established companies on behalf of a range of investors from angel investors to the shareholders of Fortune 500 companies in various companies in the life sciences arena.
His experience includes leading Sales and Marketing teams across the healthcare industry to consistently achieve and exceed growth targets. Most notably, he is a subject matter expert in Managed Care/Market Access. Many of the diagnostic products on the market today were successfully launched in large part due to his ability to secure coverage and reimbursement for novel technologies. Examples include ThinPrep (Cytyc, Quest Diagnostics), HPV (Hologic), ThyGenX and ThyraMIR (Interpace Diagnostics), myPRS and Previstage GCC (Signal Genetics), PancraGen (Interpace Diagnostics), Rituxan and Herceptin (Genentech), Ova1Plus and OvaWatch (Aspira Women’s Health) and others.
He has successfully negotiated contracts for these services with both national and regional payers as well as government payers including CMS and Medicaid. He successfully negotiated a federal bill that provides broad access to innovative testing for women with ovarian cancer. He is a frequent speaker at industry conferences where he speaks as a subject matter expert on securing coverage for novel technologies with the payer community. He holds a Bachelor of Arts degree from Westminster College where he received the Lifetime Alumni Achievement Award in 2016 and resides in New York City.